Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Lauren J. Antrim
,
Jyoti Malhotra
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
CA: A Cancer Journal for Clinicians
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
by: Maxime Borgeaud, et al.
Published: (2025)
Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification
by: Krishna S. Gunturu, et al.
Published: (2026)
Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study
by: Jian‐Chun Duan, et al.
Published: (2026)
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer
by: Carrie Printz
Published: (2025)
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy
by: Mike Fillon
Published: (2024)
